Atai Life Sciences, which is attached to Nasdaq in ATAI Life Sciences, says coded currencies like Bitcoin can be the key to survival for startups in biotechnology as they pass through years of organizational approvals, said Atai Life Sciences, which is attached to Nasdaq in Atai Life Sciences.
ATAI, which develops mental health treatments using a drug like DMT and MDMA, has become the latest public company to announce plans to buy Bitcoin.
Plan to buy $ 5 million in bitcoin (BTCHer founder and chair Christian Anzerir books In the publication of March 20.
He said: “The development of medicines is a long -term lover project.” “The steps needed to achieve organizational approval can easily take more than a decade.”
Techcrunch I mentioned In January, according to multiple data groups, the number of startups that were turned off in 2024 compared to 2023, when companies failed to obtain more funding to continue operating.
Angermayer said that the approval process is necessary to develop medicines, but it exposes companies to financial risks during Emper High interest rates in the current “winter technology” cause.
source: Christian Anzeriare
He added that the current industry approach is to put cash reserves in accounts close to scratch, as “preserving the capital was more important than obtaining a return on its cash balance.”
“This context paves the stage to consider the movements of the unconventional treasury-such as adding bitcoin to the treasury-to address the double threats of inflation and low return reserves, and in general to improve the value of shareholders and glorify them.”
Atai will join at least five other public medical companies Bought bitcoin In recent months, with the aim of strengthening the returns of shareholders.
Quantum biopharma biotechnology company He said On March 20, she now spent $ 3.5 million in a total purchase of BTC and other encrypted currencies after an initial investment of one million dollars in December.
Semler Scientific Medical Service Maker He said last month Since I started in May, a total of $ 280.4 million has spent a purchase of 3,192 BTC.
Hoth TherapeuticsACURX Pharmaceuticals and Enlivex Therapics said in sporadic Data On November 20, each of them will buy $ 1 million of bitcoin.
Related to: Michael Silor’s strategy plans to provide 5 million shares to purchase more bitcoin
Agirmayer from Atai said that Bitcoin’s purchase of his company will be primarily a long -term hedge of inflation, but also a short -term diversification play. He added that Bitcoin is likely to have short -term fluctuations for prices, and therefore the Berlin -based company often maintains the US dollar, short -term securities and shares for the required operating rate until 2027.
The ATAI position will be 5 million dollars that it is able to buy a little more than 59 BTC at its current price of about 84,300 dollars and make it the 52 largest carrying among public companies, according to Bitbo. Data.
Bitcoin has He struggled to keep standing on his feet Amid a broader market leakage due to US President Donald Trump’s threats and his fears of the American recession, which was not excluded by Trump.
The ATAI share price increased early from March 20 to its peak of $ 1.47, but pointed to closing today by 1.44 % to $ 1.37, According to To Google Finance. Its stocks sank about 93 % of her first appearance in mid -2011, but 3 % rose so far this year.
magazine: Crypting fans are obsessed with longevity and biomedus – here is the reason
publish_date
